53
Research Trials
20
Peer-reviewed publications
16
Clinical Conditions
This narrative review by Hyfe's R&D team makes the case that continuous cough monitoring (CCM), powered by acoustic AI, transforms cough from a subjective symptom into a quantifiable digital biomarker.
This ERS 2025 abstract from Hyfe's R&D team validates the wear-detection algorithm built into the Hyfe CoughMonitor smartwatch against participant-reported wear status across 418 person-hours of data in ten participants.
Authored by Hyfe's R&D team, this review synthesizes work presented at the European Respiratory Society Congress 2025 and argues that objective cough monitoring has crossed a practical threshold, moving from experimental technique to deployable clinical endpoint.
This study asked whether the core components of BCST could be embedded in a digital therapeutic and paired with continuous, objective cough monitoring inside the CoughPro app.
25.04.2022
Long coronavirus disease (COVID) refers to an array of variable and fluctuating symptomsexperienced after acute illness, with signs and symptoms that persist for 8–12 weeks andare not otherwise explicable. Cough is the most common symptom of acute COVID-19, butcough may persist in some individuals for weeks or months after recovery from acute phase.Long-COVID cough patients may get stigmatised because of the public fear of contagionand reinfection.
However, clinical characteristics and longitudinal course of long-COVIDcough have not been reported in detail, and evidence-based treatment is also lacking. In thispaper, we describe a case of long-COVID severe refractory cough with features of laryngealhypersensitivity and dysfunction. We characterized cough using patient-reported outcomesand engaged in continuous cough frequency monitoring. Through the case study, we discusspotential mechanisms, managements, and clinical implications of long-COVID refractorycough problems.
